Obesity also decreases the levels of these IGFBPs, thus increasing the bioavailability of IGF-1, promoting an increase of nutrient availability to the fetus, which can lead to overgrowth and other metabolic complications, characteristics of GDM. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.